Related Experiment Video
Updated: Sep 17, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study
Lillian Tugume1, Fiona V Cresswell1,2,3, Nicole W Engen4
1College of Health Sciences, Infectious Diseases Institute, Makerere University, Kampala Uganda.
Abstract:
We enrolled 135 adults with tuberculous meningitis (TBM), including 83% with HIV. Participants with baseline C-reactive protein (CRP) ≥40 mg/L had 3 times higher odds of an 8-week modified Rankin scale ≥4 (adjusted odds ratio, 2.78; 95% CI: 1.28-6.04; P = .010). CRP is a viable prognostic biomarker in TBM.
Insights
Elevated C-reactive protein (CRP) levels in adults with tuberculous meningitis (TBM), especially those with HIV, indicate a higher risk of poor outcomes. This inflammation marker can predict disease severity and prognosis in TBM patients.
Area of Science:
- Infectious Diseases
- Neurology
- Immunology
Background:
- Tuberculous meningitis (TBM) is a severe infection with significant morbidity and mortality.
- HIV co-infection is common in TBM cases, complicating diagnosis and treatment.
- Predictive biomarkers for TBM prognosis are needed to guide clinical management.
Purpose of the Study:
- To investigate the prognostic value of C-reactive protein (CRP) in adults with TBM.
- To assess the association between baseline CRP levels and clinical outcomes at 8 weeks.
Main Methods:
- A cohort of 135 adults with TBM was enrolled.
- Baseline CRP levels were measured.
- Modified Rankin Scale (mRS) scores were assessed at 8 weeks.
- Statistical analysis was performed to determine the odds of poor outcomes based on CRP levels.
Main Results:
- 83% of participants were living with HIV.
- Participants with a baseline CRP ≥40 mg/L had significantly higher odds of an 8-week mRS score ≥4 (aOR, 2.78; 95% CI: 1.28-6.04; P = .010).
- This association remained significant after adjustment for potential confounders.
Conclusions:
- C-reactive protein (CRP) is a viable and accessible prognostic biomarker in tuberculous meningitis.
- Elevated CRP levels at baseline can predict a worse clinical outcome in TBM patients.
- CRP measurement may aid in identifying high-risk TBM patients requiring closer monitoring and intensified treatment.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

